These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8067766)

  • 1. Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.
    Bermudez LE; Young LS; Inderlied CB
    Antimicrob Agents Chemother; 1994 May; 38(5):1200-2. PubMed ID: 8067766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.
    Bermudez LE; Petrofsky M; Inderlied CB; Young LS
    J Antimicrob Chemother; 1995 Oct; 36(4):641-6. PubMed ID: 8591938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
    Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility to rifabutin and novel fluoroquinolones in Mycobacterium avium complex isolates from patients with sputum culture-positive pulmonary disease who are undergoing standard chemotherapy].
    Tateishi Y; Motone M; Yoshimura K; Miki M; Miki K; Kitada S; Hashimoto H; Hiraga T; Maekura R
    Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):797-802. PubMed ID: 21141056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
    Yajko DM; Sanders CA; Nassos PS; Hadley WK
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2442-4. PubMed ID: 2088204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
    Klemens SP; Grossi MA; Cynamon MH
    Antimicrob Agents Chemother; 1994 Feb; 38(2):234-7. PubMed ID: 8192449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
    Klemens SP; DeStefano MS; Cynamon MH
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2413-7. PubMed ID: 1336945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies.
    Klopman G; Fercu D; Renau TE; Jacobs MR
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2637-43. PubMed ID: 8913479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
    Fattorini L; Vincent V; Li B; Xiao Y; Varnerot A; Tortoli E; Piersimoni C; Mandler F; Mascellino MT; Iona E; Orefici G
    J Chemother; 1996 Feb; 8(1):37-42. PubMed ID: 8835106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of Mycobacterium avium complex infection in AIDS patients.
    Peloquin CA
    Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.